NO974151L - 6-substituerte pyrazolo [3,4-d] pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav - Google Patents

6-substituerte pyrazolo [3,4-d] pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav

Info

Publication number
NO974151L
NO974151L NO974151A NO974151A NO974151L NO 974151 L NO974151 L NO 974151L NO 974151 A NO974151 A NO 974151A NO 974151 A NO974151 A NO 974151A NO 974151 L NO974151 L NO 974151L
Authority
NO
Norway
Prior art keywords
pyrimidin
methods
substituted pyrazolo
preparations
ones
Prior art date
Application number
NO974151A
Other languages
English (en)
Norwegian (no)
Other versions
NO974151D0 (no
Inventor
Edward R Bacon
Sol J Daum
Baldev Singh
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of NO974151D0 publication Critical patent/NO974151D0/no
Publication of NO974151L publication Critical patent/NO974151L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO974151A 1995-03-10 1997-09-09 6-substituerte pyrazolo [3,4-d] pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav NO974151L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/402,268 US5656629A (en) 1995-03-10 1995-03-10 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof
PCT/US1996/002971 WO1996028429A1 (en) 1995-03-10 1996-03-05 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF

Publications (2)

Publication Number Publication Date
NO974151D0 NO974151D0 (no) 1997-09-09
NO974151L true NO974151L (no) 1997-11-04

Family

ID=23591222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974151A NO974151L (no) 1995-03-10 1997-09-09 6-substituerte pyrazolo [3,4-d] pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav

Country Status (13)

Country Link
US (2) US5656629A (cs)
EP (1) EP0813527A4 (cs)
JP (1) JPH11501923A (cs)
KR (1) KR19980702891A (cs)
AU (1) AU708750B2 (cs)
CA (1) CA2211669A1 (cs)
CZ (1) CZ280597A3 (cs)
HU (1) HUP9801336A3 (cs)
NO (1) NO974151L (cs)
NZ (1) NZ306035A (cs)
PL (1) PL322380A1 (cs)
WO (1) WO1996028429A1 (cs)
ZA (1) ZA961947B (cs)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500789A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Acylierte 5-Aminopyrazole
DE19709877A1 (de) * 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
PL336586A1 (en) 1997-04-25 2000-07-03 Pfizer Pyrazoylpyrimidinones inhibiting the cyclic guanosine 3',5'-monophosphate phosphodiesterase of type 5 (cgmp pde5) for treating sexual disorders
GB9722520D0 (en) 1997-10-24 1997-12-24 Pfizer Ltd Compounds
HUP0102543A3 (en) * 1998-04-20 2002-01-28 Pfizer Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction and medicaments containing them
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
GB9823101D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823102D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823103D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
UA67802C2 (uk) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
US6225315B1 (en) * 1998-11-30 2001-05-01 Pfizer Inc Method of treating nitrate-induced tolerance
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
EP1222190A1 (en) 1999-10-11 2002-07-17 Pfizer Limited 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
CA2395418A1 (en) * 1999-12-24 2001-07-05 Bayer Aktiengesellschaft Isoxazolo pyrimidinones and the use thereof
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
US20040077664A1 (en) * 2001-01-31 2004-04-22 Hans-Michael Eggenweiler Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
EP1423080A4 (en) * 2001-03-01 2009-06-03 Conforma Therapeutics Corp PROCESS FOR TREATING PROLIFERATIVE GENETIC DISORDERS WITH HSP90 INHIBITORS
DE10135815A1 (de) * 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
JP4397691B2 (ja) * 2001-10-30 2010-01-13 コンフォーマ・セラピューティクス・コーポレイション Ｈｓｐ９０阻害活性を有するプリン類似体
WO2003049679A2 (en) * 2001-12-06 2003-06-19 Merck & Co., Inc. Mitotic kinesin inhibitors
EP1458726B1 (en) * 2001-12-06 2009-07-15 Merck & Co., Inc. Mitotic kinesin inhibitors
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
DE10238723A1 (de) 2002-08-23 2004-03-11 Bayer Ag Phenyl-substituierte Pyrazolyprimidine
DE10238724A1 (de) * 2002-08-23 2004-03-04 Bayer Ag Alkyl-substituierte Pyrazolpyrimidine
DE10238722A1 (de) * 2002-08-23 2004-03-11 Bayer Ag Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
WO2004096810A1 (en) 2003-04-29 2004-11-11 Pfizer Limited 5,7-diaminopyrazolo`4,3-d!pyrimidines useful in the treatment of hypertension
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
US8044060B2 (en) * 2003-05-09 2011-10-25 Boehringer Ingelheim International Gmbh 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
DE10320785A1 (de) * 2003-05-09 2004-11-25 Bayer Healthcare Ag 6-Arylmethyl-substituierte Pyrazolopyrimidine
DE10328479A1 (de) * 2003-06-25 2005-01-13 Bayer Ag 6-Arylamino-5-cyano-4-pyrimidinone
KR20060070572A (ko) * 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Ｈｓｐ90-저해제로서의 신규 헤테로시클릭 화합물
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
DE102004001873A1 (de) * 2004-01-14 2005-09-29 Bayer Healthcare Ag Cyanopyrimidinone
WO2005085248A1 (en) * 2004-02-27 2005-09-15 F.Hoffmann-La Roche Ag Heteroaryl-fused pyrazolo derivatives
EP1732541A4 (en) 2004-04-07 2008-03-05 Takeda Pharmaceutical CYCLIC COMPOUNDS
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
MX2008002385A (es) * 2005-08-25 2008-03-18 Hoffmann La Roche Inhibidores de proteinas cinasas activads por mitogenos p38 y metodos para utilizarlos.
US20070105874A1 (en) * 2005-09-23 2007-05-10 Conforma Therapeutics Corporation Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 Inhibitors
CN101287738B (zh) 2005-10-11 2011-08-10 弗·哈夫曼-拉罗切有限公司 咪唑并苯并二氮杂*衍生物
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
US9255099B2 (en) 2006-06-06 2016-02-09 Intra-Cellular Therapies, Inc. Pyrazolo[3,4-D]pyrimidine-4,6(5H,7H)-diones as phosphodiesterase 1 inhibitors
CA2716334A1 (en) * 2007-11-13 2009-05-22 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
US8648085B2 (en) * 2007-11-30 2014-02-11 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
KR20100094551A (ko) 2007-12-06 2010-08-26 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
PE20110383A1 (es) 2008-09-08 2011-07-15 Boehringer Ingelheim Int Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a)
EP2367431B1 (en) 2008-12-06 2015-08-05 Intra-Cellular Therapies, Inc. Organic compounds
BRPI0922809A2 (pt) 2008-12-06 2018-05-29 Intracellular Therapies Inc compostos orgânicos
SG171777A1 (en) 2008-12-06 2011-07-28 Intra Cellular Therapies Inc Organic compounds
JP5542196B2 (ja) 2009-03-31 2014-07-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １−複素環−１，５−ジヒドロ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体及びｐｄｅ９ａモジュレーターとしてのそれらの使用
TW201118099A (en) * 2009-08-12 2011-06-01 Boehringer Ingelheim Int New compounds for the treatment of CNS disorders
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9434730B2 (en) 2010-05-31 2016-09-06 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
PL2603511T3 (pl) 2010-08-12 2017-08-31 Boehringer Ingelheim Int Pochodne 6-cykloalkilo-1,5-dihydropirazolo[3,4-d]pirymidyn-4-onu i ich zastosowanie jako inhibitorów PDE9A
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
EP2508511A1 (en) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
CN102786525B (zh) * 2012-08-08 2014-12-17 中山大学 N-取代吡唑并[3,4-d]嘧啶酮类化合物、其制备方法及其应用
WO2015088885A1 (en) * 2013-12-11 2015-06-18 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
WO2015088886A1 (en) * 2013-12-11 2015-06-18 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
US10934291B2 (en) 2014-09-25 2021-03-02 Duke University Kinase inhibitors and related methods of use
KR102590848B1 (ko) * 2016-12-28 2023-10-19 다트 뉴로사이언스, 엘엘씨 Pde2 억제제로서 치환된 피라졸로피리미디논 화합물
JP7254078B2 (ja) 2017-11-27 2023-04-07 ダート・ニューロサイエンス・エルエルシー Ｐｄｅ１阻害剤としての置換フラノピリミジン化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165520A (en) * 1965-01-12 Certificate of correction
CA754565A (en) * 1967-03-14 A. Burch Homer 4-substituted-1-alkyl-6-(2-furyl)-1h-pyrazolo(3,4-d)pyrimidines
US3211732A (en) * 1965-10-12 Pyrazolob:x-d]pyrlil/hdines
CH398626A (de) * 1960-05-11 1966-03-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
GB937722A (en) * 1960-05-11 1963-09-25 Ciba Ltd New pyrazolopyrimidines and process for the preparation thereof
FR206F (cs) * 1965-07-20
GB1284084A (en) * 1969-04-17 1972-08-02 Delmar Chem PROCESS FOR MAKING 1H-PYRAZOLO[3,4-d]PYRIMIDINES
BE758050A (fr) * 1969-10-28 1971-04-27 Geigy Ag J R Derives 5-nitro-furyliques et medicaments contenant de tels composes
US3732225A (en) * 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
DE2116973A1 (de) * 1971-04-07 1972-12-14 Bayer Ag, 5090 Leverkusen Polymerisierbare Anthranilsäureester
US3847908A (en) * 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
US4260758A (en) * 1979-09-17 1981-04-07 Burroughs Wellcome Co. Pyrazolo (3,4-d) pyrimidines and methods of making
US4666908A (en) * 1985-04-05 1987-05-19 Warner-Lambert Company 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
US5075310A (en) * 1988-07-01 1991-12-24 Smith Kline & French Laboratories, Ltd. Pyrimidone derivatives as bronchodilators
GB9008166D0 (en) * 1990-04-10 1990-06-06 Thompson Andrew Improved high performance carpet tile backing
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9121028D0 (en) * 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
MX9706876A (es) 1998-06-28
AU5418896A (en) 1996-10-02
US5656629A (en) 1997-08-12
NZ306035A (en) 1999-07-29
CZ280597A3 (cs) 1998-04-15
KR19980702891A (ko) 1998-08-05
WO1996028429A1 (en) 1996-09-19
HUP9801336A3 (en) 2000-07-28
CA2211669A1 (en) 1996-09-19
EP0813527A1 (en) 1997-12-29
EP0813527A4 (en) 1998-09-09
ZA961947B (en) 1996-10-07
PL322380A1 (en) 1998-01-19
AU708750B2 (en) 1999-08-12
US5977118A (en) 1999-11-02
HUP9801336A2 (hu) 1998-10-28
JPH11501923A (ja) 1999-02-16
NO974151D0 (no) 1997-09-09

Similar Documents

Publication Publication Date Title
NO974151L (no) 6-substituerte pyrazolo [3,4-d] pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav
NO984082D0 (no) Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremstilling derav
EP0768312A3 (en) Bis-Staurosporine and K-252a derivatives
CA2388140A1 (en) Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
ATE182892T1 (de) Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren
NO984081D0 (no) Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
TR199900048T2 (xx) Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler
CA2226784A1 (en) Use of cgmp-phosphodiesterase inhibitors to treat impotence
KR950700909A (ko) 포스포디에스테라제 억제제로서의 피리도[2,3-d]피리미딘 유도체(Pyrido [2,3-d]pyrimidine derivatives as phosphodiesterase inhibitors)
DZ3154A1 (fr) 1-Amino triazolo(4,3-A)quinazoline-5-ones et/ou-5-thiones inhibitrices de phosphodiestérases IV.
NO974150D0 (no) 6-arylpyrazolo(3,4-d)pyrimidin-4-oner og preparater og fremgangsmåter for anvendelse derav
AU4707689A (en) Phenylsulfamoyl-1,2,4-triazolo(1,5-a)pyrimidines
HUP0004544A3 (en) Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
FI973691A (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
CA2159451A1 (en) Unsaturated Phosphonates Derivatives of Purines and Pyrimidines
HU9402253D0 (en) Trisubstituter pyrimido [5,4-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for producing them
AU6131094A (en) Nucleoside derivatives and their use as excitatory amino acid antagonists
NZ324118A (en) Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants
AU3539795A (en) Methods of treating cold symptoms using pentoxifylline
IL150163A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND SOME NOVEL SUCH COMPOUNDS
AU7666496A (en) Structure based design of inhibitors of hiv-1 reverse transcriptase
AU5589294A (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
AU3826085A (en) Tetrazolo(1,5-a)(1,2,4)triazolo(1,5-c)pyrimidines
DE69517767D1 (de) IMIDAZOLYLALKYLDERIVATE VON IMIDAZO[1,5-a]INDOL-3-ON UND IHRE VERWENDUNG ALS ARZNEIMITTEL
AU4354493A (en) Orally administrable composition of pyrido(1,2-a)pyrimidine derivative